首页> 美国卫生研究院文献>Journal of Pharmaceutical Policy and Practice >Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety
【2h】

Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety

机译:在COVID-19中:发展积极的药物不良反应(ADR)和医疗器械事件(MDI)报告文化对于全球卫生和公共安全的重要性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Examples of Instances for ADR reporting. Several types of ADRs warrant reporting to Health Canada. All suspected serious ADRs must be reported, as well as delayed or quick onset ADRs. Even when an ADR is not certain, it is best practice to report the event to Health Canada
机译:ADR报告实例的示例。几种类型的ADR需要向加拿大卫生部报告。必须报告所有可疑的严重ADR,以及延迟或快速发作的ADR。即使不确定ADR,最好还是向加拿大卫生部报告该事件

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号